BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valats JC, Tuaillon E, Funakoshi N, Hoa D, Brabet MC, Bolloré K, Ducos J, Vendrell JP, Blanc P. Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination. Vaccine 2010;28:6411-6. [PMID: 20682363 DOI: 10.1016/j.vaccine.2010.07.058] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Borzooy Z, Jazayeri SM, Mirshafiey A, Khamseh A, Mahmoudie MK, Azimzadeh P, Geravand B, Boroumand MA, Afshar M, Poortahmasebi V. Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination. Germs. 2015;5:134-140. [PMID: 26716102 DOI: 10.11599/germs.2015.1081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
2 Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, Trevisan A. Hepatitis B vaccination of adolescents: Significance of non-protective antibodies. Vaccine 2013;32:62-8. [DOI: 10.1016/j.vaccine.2013.10.074] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
3 Pondé RADA. Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity. Arch Virol 2019;164:2645-58. [DOI: 10.1007/s00705-019-04369-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
4 Tian C, Chen Y, Liu Y, Wang S, Li Y, Wang G, Xia J, Zhao XA, Huang R, Lu S, Wu C. Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans. Emerg Microbes Infect 2018;7:16. [PMID: 29449582 DOI: 10.1038/s41426-018-0034-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
5 Ma Z, Zhang E, Gao S, Xiong Y, Lu M. Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response. Front Immunol 2019;10:2308. [PMID: 31608073 DOI: 10.3389/fimmu.2019.02308] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
6 Cassaniti I, Calarota SA, Adzasehoun KM, Chiesa A, Comolli G, Parea M, Baldanti F. Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects. Hum Vaccin Immunother 2016;12:2927-33. [PMID: 27392260 DOI: 10.1080/21645515.2016.1204500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Körber N, Pohl L, Weinberger B, Grubeck-Loebenstein B, Wawer A, Knolle PA, Roggendorf H, Protzer U, Bauer T. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24highCD38high Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders. Front Immunol 2021;12:713351. [PMID: 34566969 DOI: 10.3389/fimmu.2021.713351] [Reference Citation Analysis]
8 Taguchi M, Namikawa K, Maruo T, Orito K, Lynch J, Tsuchiya R, Sahara H. Booster effect of canine distemper, canine parvovirus infection and infectious canine hepatitis combination vaccine in domesticated adult dogs. Microbiol Immunol 2012;56:579-82. [PMID: 22672137 DOI: 10.1111/j.1348-0421.2012.00475.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Abd El-Wahab EW, Metwally M, Lotfy N. Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies. Trop Med Int Health 2021;26:882-94. [PMID: 33860608 DOI: 10.1111/tmi.13588] [Reference Citation Analysis]
10 Swift MD, Behrman AJ. Vaccines for Health Care Personnel. Mayo Clin Proc 2019;94:2127-41. [PMID: 31515104 DOI: 10.1016/j.mayocp.2019.01.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Nicoli F, Mantelli B, Gallerani E, Telatin V, Bonazzi I, Marconi P, Gavioli R, Gabrielli L, Lazzarotto T, Barzon L, Palù G, Caputo AA. HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in Italy. Vaccines (Basel) 2020;8:E26. [PMID: 31947611 DOI: 10.3390/vaccines8010026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Lin X, Twelkmeyer T, Zhu D, Zhang L, Zhao Y, Zhang C, Iwakura Y, Meng G, Hua Z, Yan B, Liu WJ, Luo Z, Gong S, Chen H, Li S, Hou B, Tang H. Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin. Proc Natl Acad Sci U S A 2021;118:e2019798118. [PMID: 33875594 DOI: 10.1073/pnas.2019798118] [Reference Citation Analysis]
13 Trevisan A, Mason P, Nicolli A, Maso S, Fonzo M, Scarpa B, Bertoncello C. Future Healthcare Workers and Hepatitis B Vaccination: A New Generation. Int J Environ Res Public Health 2021;18:7783. [PMID: 34360071 DOI: 10.3390/ijerph18157783] [Reference Citation Analysis]
14 Wu ZQ, Tan L, Gan WQ, Mo ZS, Chen DB, Wang PP, Zhao QY, Xie DY, Gao ZL. The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α. Ann Transl Med 2021;9:414. [PMID: 33842635 DOI: 10.21037/atm-21-409] [Reference Citation Analysis]
15 Rosado MM, Scarsella M, Pandolfi E, Cascioli S, Giorda E, Chionne P, Madonne E, Gesualdo F, Romano M, Ausiello CM, Rapicetta M, Zanetti AR, Tozzi A, Carsetti R. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example. Eur J Immunol 2011;41:1800-8. [PMID: 21469123 DOI: 10.1002/eji.201041187] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
16 Doedée AM, Kannegieter N, Öztürk K, van Loveren H, Janssen R, Buisman AM. Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination. Vaccine 2016;34:2281-9. [PMID: 26721327 DOI: 10.1016/j.vaccine.2015.12.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
17 Zaffina S, Marcellini V, Santoro AP, Scarsella M, Camisa V, Vinci MR, Musolino AM, Nicolosi L, Rosado MM, Carsetti R. Repeated vaccinations do not improve specific immune defenses against Hepatitis B in non-responder health care workers. Vaccine. 2014;32:6902-6910. [PMID: 25444815 DOI: 10.1016/j.vaccine.2014.10.066] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
18 Momeni N, Ahmad Akhoundi MS, Alavian SM, Shamshiri AR, Norouzi M, Mahboobi N, Moosavi N, Jazayeri SM. HBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measures. Hepat Mon 2015;15:e20014. [PMID: 25741367 DOI: 10.5812/hepatmon.20014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
19 Halperin SA, Ward BJ, Dionne MS, Langley JM, Mcneil SA, Smith B, Mackinnon-cameron D, Heyward WL, Martin JT. Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine. Human Vaccines & Immunotherapeutics 2013;9:1438-44. [DOI: 10.4161/hv.24256] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
20 Qiu S, He P, Fang X, Tong H, Lv J, Liu J, Zhang L, Zhai X, Wang L, Hu Z, Yu Y. Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis. Hum Vaccin Immunother. 2018;14:1763-1772. [PMID: 29580160 DOI: 10.1080/21645515.2018.1450122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]